Alzheimer's disease, often abbreviated as AD, represents a multifaceted neurological condition that exerts a substantial influence on the elderly demographic. Its onset involves pathological ...

“Yeah to see a smile on her face and to be able to laugh and smile with your loved one as you walk the path of Alzheimer’s, ...

Alzheimer’s disease is a relentless and progressive disease that affects approximately 6.9 million people in the United States. The disease progresses slowly over 10-20 years. During that time ...

Alzheimer’s Society is committed to supporting early career researchers, recognising them as the future of dementia research. We are investing £9m into new, transformative Doctoral Training Centres ...

A new study has found an answer for a long-lasting question in aging research - Is Alzheimer’s disease-dementia a form of accelerated aging or is there a different path that can lead us to ...

Analysis of 1.6 million brain cells from older adults has captured the cellular changes that occur in Alzheimer's early stages, revealing potential new targets and routes for prevention.

Share on Pinterest Researchers have uncovered a genetic link between heart disease and Alzheimer’s. Image credit: Maciej Frolow/Getty Images. There is a known association between Alzheimer’s ...

No matter what type of dementia you have, we’re here for you. Alzheimer's Society offers a range of support services. From a listening ear on the phone to a visit in person and opportunities to ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

(RTTNews) - Hoth Therapeutics, Inc. (HOTH) Tuesday announced promising preclinical results for its investigational Alzheimer's drug, HT-ALZ. The company's shares were rising more than 15 percent ...

Recently approved medication is showing success at slowing down the cognitive decline caused by Alzheimer's disease. But experts are cautioning that the drug is not for all patients. [ TNS ] A new ...

The failure to diagnose Alzheimer's disease, the most common form of dementia in the elderly, at an early stage of molecular pathology is considered a major reason why treatments fail in clinical ...